First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases

Different factors, not limited to the lung, influence the progression of ILDs. A “treatable trait” strategy was recently proposed for ILD patients as a precision model of care to improve outcomes. However, no data have been published so far on the prevalence of TTs in ILD. A prospective, observation...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Biomedicines Ročník 12; číslo 5; s. 1047
Hlavní autoři:	Amati, Francesco, Stainer, Anna, Maruca, Giacomo, De Santis, Maria, Mangiameli, Giuseppe, Torrisi, Chiara, Bossi, Paola, Polelli, Veronica, Blasi, Francesco, Selmi, Carlo, Marulli, Giuseppe, Balzarini, Luca, Terracciano, Luigi Maria, Gatti, Roberto, Aliberti, Stefano
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland MDPI AG 01.05.2024
Témata:	Airway management Asthma Cardiology Chronic obstructive pulmonary disease Clinical outcomes Comorbidity Connective tissue diseases Cough Development and progression Emphysema endotypes Genotype & phenotype interstitial lung diseases Kinases Lung diseases Medical prognosis Patients Pharmaceutical industry phenotypes Population studies Precision medicine Quality of life Respiratory diseases Respiratory failure Sarcoidosis treatable traits Treprostinil Germany endotypes treatable traits phenotypes interstitial lung diseases
ISSN:	2227-9059, 2227-9059
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!